Close Menu

City of Hope

Using baseline blood samples, researchers have identified an eight-gene expression signature to predict patient responses to Zytiga plus prednisone or Xtandi.

The HOPE-Genomics tool features patient-friendly genetic test reports and virtual educational resources to explain the implications of results.

City of Hope and Texas Oncology are the first customers for Trapelo, a decision support platform from Innovation Insights that involves labs and payors.